Techh.info/biomedtechnology hourly

Cancer

headlines texts
14.07.2020
01:25 News-Medical.Net Baylor Scott & White Research Institute receives NIH award for esophageal cancer study

The incidence of esophageal adenocarcinoma has increased 8-fold over the past 50 years. This is one of the deadliest cancers, with a five-year survival rate of only 20 percent. However, the survival rate more than doubles if the cancer is identified early.

Скрыть анонс
00:59 News-Medical.Net Novel drug could enable the immune system to attack ovarian cancer

A drug known as SP-2577 could help enable the body's own immune system to attack ovarian cancer, according to a study led by the Translational Genomics Research Institute, an affiliate of City of Hope.

Скрыть анонс
13.07.2020
19:05 Medscape.Com ADAURA Trial Changes Lung Cancer Treatment in Two Important Ways

Dr Mark Kris discusses recent practice-changing abstracts in lung cancer, presented at the virtual 2020 ASCO meeting.

Скрыть анонс
17:49 Drugs.com Does Medical Marijuana Help or Harm Kids With Cancer?

MONDAY, July 13, 2020 -- Parents are increasingly interested in whether medical marijuana can help their children with problems like cancer-related pain and nausea -- but there's concern about interactions with their medications and a general lack...

Скрыть анонс
17:05 News-Medical.Net Parent-based intervention helps reboot healthy eating habits in child cancer survivors

Fussy eating and taste changes are common side effects of cancer treatment – now, a healthy eating program designed by UNSW medical researchers wants to help parents get their child’s diet back on track.

Скрыть анонс
15:31 News-Medical.Net Breakthrough discovery could lead to ‘kinder’ treatments for childhood bone cancer

Researchers at the University of East Anglia and University of Manchester have made an important breakthrough that could lead to ‘kinder’ treatments for children with bone cancer, and save lives.

Скрыть анонс
09:24 BBC Health 'Breakthrough' cancer study adds to Super Strong Sophie's legacy

The father of a five-year-old who died from cancer says he is proud she could help researchers.

Скрыть анонс
12.07.2020
06:38 News-Medical.Net Fatty acid can kill human cancer cells, study shows

Researchers have demonstrated that a fatty acid called dihomogamma-linolenic acid, or DGLA, can kill human cancer cells.

Скрыть анонс
11.07.2020
22:00 News-Medical.Net Newly identified gene variants in Black Americans could lead to precision prostate cancer therapies

Black men in the United States are known to suffer disproportionately from prostate cancer, but few studies have investigated whether genetic differences in prostate tumors could have anything to do with these health disparities.

Скрыть анонс
20:40 News-Medical.Net Innovative system aims to improve predictions of survival indicators in breast cancer patients

Improving the predictions of survival indicators in breast cancer patients through artificial intelligence and probabilistic modeling tools is the goal of ModGraProDep, an innovative system presented in a study published in the journal Artificial Intelligence in Medicine.

Скрыть анонс
00:15 Drugs.com Blacks Underrepresented in Cancer Drug Trials: Study

FRIDAY, July 10, 2020 -- U.S. government-funded clinical trials for new cancer treatments have more Black participants than those run by drug companies, but Blacks are still underrepresented in cancer studies, researchers say. The SWOG Cancer...

Скрыть анонс
10.07.2020
14:52 FierceBiotech.com Harbour BioMed nabs meaty C round as cancer, COVID-19 work draws investors

Harbour BioMed nabs meaty C round as cancer, COVID-19 work draws investors badams Fri, 07/10/2020 - 05:12

Скрыть анонс
09:38 News-Medical.Net Upcoming phase II study on high risk of triple negative breast cancer recurrence

Indiana University School of Medicine researchers Milan Radovich, PhD, and Bryan Schneider, MD, have discovered that the presence of circulating tumor DNA (ctDNA) and circulating tumor cells (CTCs) in the plasma of women's blood who have undergone chemotherapy prior to surgery for the treatment of stage 1, 2 or 3 triple negative breast cancer are critical indicators for the prediction of disease recurrence and disease-free survival.

Скрыть анонс
06:10 News-Medical.Net New cancer vaccine shows promising signs in preclinical studies

Scientists are ready to trial a new cancer vaccine in humans following the successful outcome of their preclinical studies.

Скрыть анонс
04:28 News-Medical.Net Expansion stress promotes aggressive tumor cell growth in breast cancer

Expansion stress can have an alarming impact on breast cancer cells by creating conditions that could lead to dangerous acceleration of the disease, an interdisciplinary team of University of Alabama at Birmingham researchers has found.

Скрыть анонс
03:40 News-Medical.Net Immunicom and Sheba Medical Center initiate clinical trial to evaluate novel cancer treatment

Sheba Medical Center at Tel HaShomer and Immunicom, Inc. are initiating a ground-breaking clinical trial to evaluate the clinical effectiveness of the Immunicom LW-02 plasma filtration device as a monotherapy and in combination with an anti-PD-1 immune checkpoint inhibitor.

Скрыть анонс
03:10 News-Medical.Net Mapping immune landscape of hematological malignancies may help improve cancer therapies

Activating the immune system of the body is a promising form of treatment for cancer. Researchers at the University of Helsinki and Helsinki University Hospital as well as the University of Eastern Finland mapped out the immune landscape of hematological malignancies in a dataset covering more than 10,000 patients to identify drug targets and patient groups which could potentially benefit from immunotherapies.

Скрыть анонс
02:57 News-Medical.Net Overzealous guardians in the cells could increase cancer risk

Researchers at the UiO and OUS have discovered how destructive changes occur in our genome. This could lead to cancer. Their results have been published in the journal Nature Cell Biology.

Скрыть анонс
09.07.2020
23:13 StemCellsPortal.coml Gene Edited and Engineered Cell-based Therapeutics for Cancer

Discussion of stem cells and cancer cell-based therapeutics that have been tested in mouse models of cancer in recent years and are quickly moving toward translation.Co-Chairs and Speakers Khalid Shah (Harvard Medical School, USA)Massimo Dominici (University of Modena and Reggio Emilia, Italy) Massimo Dominici - Engineering MSCs Against Tumors Massimo Dominici began his talk with a discussion of his work regarding using mesenchymal stem cells (MSCs) as autologous anti-tumor agents, given the inherent ability of MSCs to target tumors after administration. The sampling of MSCs from patients followed by their modification with anti-cancer agent encoding genes and their subsequent expansion provides a treatment option for patients suffering from cancers such as sarcomas, pancreatic cancer, or

Скрыть анонс
20:05 News-Medical.Net Breast cancer cells can reprogram natural killer cells to aid in metastasis

Natural killer cells, a type of immune cell, are known to limit metastasis by inducing the death of cancer cells. But metastases still form in patients, so there must be ways for cancer cells to escape.

Скрыть анонс
19:20 Phys.org Overzealous cell membrane guardians could increase the risk of cancer

Researchers at the UiO and OUS have discovered how destructive changes occur in our genome. This could lead to cancer. Their results have been published in the journal Nature Cell Biology.

Скрыть анонс
19:14 ScienceDaily.com Study sheds light on how cancer spreads in blood

A new study sheds light on proteins in particles called extracellular vesicles, which are released by tumor cells into the bloodstream and promote the spread of cancer. The findings suggest how a blood test involving these vesicles might be used to diagnose cancer in the future, avoiding the need for invasive surgical biopsies.

Скрыть анонс
18:31 News-Medical.Net ACTIONED consortium aims to transform future treatment of colorectal cancer patients

The Precision Medicine Centre of Excellence (PMC) at Queen's is leading a ground-breaking collaboration with the world's largest biotech company Roche, and Artificial Intelligence (AI) specialist, Sonrai Analytics.

Скрыть анонс
17:15 FierceBiotech.com Preventing breast cancer metastasis by reactivating natural killer immune cells

Preventing breast cancer metastasis by reactivating natural killer immune cells aliu Thu, 07/09/2020 - 05:25

Скрыть анонс
16:14 StemCellsPortal.coml Topic Session - Gene Edited and Engineered Cell-based Therapeutics for Cancer

Discussion of stem cells and cancer cell-based therapeutics that have been tested in mouse models of cancer in recent years and are quickly moving toward translation.Co-Chairs and Speakers Khalid Shah (Harvard Medical School, USA)Massimo Dominici (University of Modena and Reggio Emilia, Italy) Massimo Dominici - Engineering MSCs Against Tumors Massimo Dominici began his talk with a discussion of his work regarding using mesenchymal stem cells (MSCs) as autologous anti-tumor agents, given the inherent ability of MSCs to target tumors after administration. The sampling of MSCs from patients followed by their modification with anti-cancer agent encoding genes and their subsequent expansion provides a treatment option for patients suffering from cancers such as sarcomas, pancreatic cancer, or glioblastoma. The choice to focus on pancreatic ductal

Скрыть анонс
14:17 ScientificAmerican.Com COVID-19 Is Forcing Us to Rethink Clinical Trials for Cancer Treatments

Participation rates were already low, but the pandemic threatens to drive them even lower -- Read more on ScientificAmerican.com

Скрыть анонс
08:42 News-Medical.Net Breast cancer simulation models can guide screening recommendations for women

Chest radiation is used to treat children with Hodgkin and non-Hodgkin lymphoma as well as lung metastases in various solid tumors.

Скрыть анонс
08.07.2020
19:07 News-Medical.Net Cocktail of chemotherapy drugs may be safe, effective for patients with metastatic pancreatic cancer

Pancreatic cancer carries a poor prognosis, and it often goes undetected until advanced stages. A new BJS (British Journal of Surgery) study indicates that a certain cocktail of chemotherapy drugs may be a safe and effective treatment option for patients with a metastatic form of the disease.

Скрыть анонс
18:54 Technology.org Aichi Cancer Center and NEC Launch Joint Research on Fundamental Study Aimed at Advanced Cancer Immunotherapy

Aichi Cancer Center(1) and NEC Corporation (NEC; 6701) today announced the launch of fundamental research aiming to realize

Скрыть анонс
18:24 AzoNano.com Unique Nanoparticle Increases Effectiveness of Cancer Treatment

According to Penn State scientists, a special nanoparticle used to provide a localized cancer treatment suppresses the growth of tumors. A team of Penn State researchers is collaborating on a...

Скрыть анонс
17:40 Drugs.com From 'Dead Man Walking' to Dancing Once More: One Man's Cancer Journey

WEDNESDAY, July 8, 2020 -- After spending much of 2016 healing following the deaths of both his partner of 25 years and his mother, Oswald Peterson -- a professional carnival dancer in New York City -- was convinced 2017 would be his year to start...

Скрыть анонс
17:23 Phys.org Checkpoint blockade by a D-peptide for cancer immunotherapy

Our immune system ought to be able to recognize and kill tumor cells. However, many tumors deceive the immune system. For example, they induce the so-called immune checkpoints of T-cells to shut down immune responses. In the journal Angewandte Chemie, scientists have now introduced a new approach for immunological tumor treatment. Their method is based on the specific blockade of an immune checkpoint by a stable "mirror-image" peptide.

Скрыть анонс
17:08 FierceBiotech.com Fine-tuning regulatory T cells to treat cancer and autoimmune diseases

Fine-tuning regulatory T cells to treat cancer and autoimmune diseases aliu Wed, 07/08/2020 - 07:55

Скрыть анонс
15:49 News-Medical.Net World's first clinical trial of immune-boosting strategy to protect cancer patients from COVID-19

In the race to find new ways to prevent and treat COVID-19, Canadian researchers have launched an innovative clinical trial focussed on strengthening the immune system for one of the most vulnerable populations - cancer patients.

Скрыть анонс
15:06 FierceBiotech.com Merck teams up with cancer startup Foghorn in $425M deal

Merck teams up with cancer startup Foghorn in $425M deal badams Wed, 07/08/2020 - 07:38

Скрыть анонс
11:14 AzoNano.com Unique Nanoparticle can Increase Overall Effectiveness of Cancer Treatment

A unique nanoparticle to deliver a localized cancer treatment inhibits tumor growth in mice, according to a team of Penn State researchers. The nanoparticles, developed by Daniel Hayes, associate...

Скрыть анонс
09:39 News-Medical.Net Study find researchers delivered nanoparticles to the cancer cells of mice through IV

A unique nanoparticle to deliver a localized cancer treatment inhibits tumor growth in mice, according to a team of Penn State researchers.

Скрыть анонс
09:25 Technology.org Species could hold a cure for melanoma, the most dangerous type of skin cancer

Could the cure for melanoma — the most dangerous type of skin cancer — be a compound derived

Скрыть анонс
04:32 News-Medical.Net Aspirin and flavonoids in fruits and vegetables could help prevent colorectal cancer

A diet rich in fruits and vegetables and a daily dose of aspirin have one thing in common-;both can help prevent colorectal cancer. Yet scientists have struggled for decades to find the source of their ability to inhibit cancer cell growth.

Скрыть анонс
01:22 NYT Health Judge Puts Cloud Over Settlement of Roundup Cancer Claims

An agreement for the weedkiller’s maker to pay more than $10 billion to end litigation may not get court approval.

Скрыть анонс
00:45 Drugs.com New Guidelines Could Double Number Eligible for Lung Cancer Screening

TUESDAY, July 7, 2020 -- CT scans have been proven to help spot lung cancer early and save lives. Now, updated expert recommendations could double the number of Americans who are eligible for the yearly screening. The recommendations -- from the...

Скрыть анонс
07.07.2020
18:07 Phys.org Protein linked to cancer acts as a viscous glue in cell division

An over-abundance of the protein PRC1, which is essential to cell division, is a telltale sign in many cancer types, including prostate, ovarian, and breast cancer. New research, published online today in Developmental Cell, shows that PRC1 acts as a "viscous glue" during cell division, precisely controlling the speed at which two sets of DNA are separated as a single cell divides. The finding could explain why too much or too little PRC1 disrupts that process and causes genome errors linked to cancer.

Скрыть анонс
17:51 News-Medical.Net New web-based tool could contribute to the development of better cancer treatments

The results are now published in Nature Medicine and at the same time the tool - the Molecular Tumor Board Portal - will be launched on www.mtbp.org. Janne Lehtiö, professor at the Karolinska Institutet Department of Oncology-Pathology led this work, along with researcher David Tamborero.

Скрыть анонс
17:08 Medscape.Com Antihypertensives Linked to Reduced Risk of Colorectal Cancer

A large retrospective study showed a reduced risk of developing colorectal cancer among persons who used commonly prescribed antihypertensive medications.

Скрыть анонс
12:50 ClinicalOncology.com Keytruda Approved for Recurrent or Metastatic Cutaneous Squamous Cell Cancer

The FDA approved pembrolizumab (Keytruda, Merck) for patients with recurrent or metastatic cutaneous squamous cell carcinoma (cSCC) that is not curable by surgery or radiation. 

Скрыть анонс
12:46 News-Medical.Net Cancer Research UK and Abcam launch custom partnership to accelerate cancer research

Today, Cancer Research UK, the world’s largest independent funder of cancer research and Abcam plc, a global innovator in life science reagents and tools, are pleased to announce a new partnership for the development and commercialization of novel custom antibodies to support the acceleration of cancer research.

Скрыть анонс
09:09 News-Medical.Net Researchers develop new technique to sort out complex interactions unique to prostate cancer cells

UT Southwestern researchers have identified vast webs of small snippets of the genome that interact with each other and with genes to promote prostate cancer.

Скрыть анонс
04:57 News-Medical.Net Researchers create new tool to identify cancer-causing mutations lurking in 98% of the genome

Gene coding regions constitute 2% of the human genome. St. Jude Children's Research Hospital scientists have developed a computational tool to identify alterations that drive tumor formation in the remaining 98% of the genome.

Скрыть анонс
01:39 News-Medical.Net Moffitt researchers discover key protein involved in cancer metastasis

Cancer is complex and unpredictable. Despite successful treatment or years of remission, there is always a chance that a patient's cancer can return.

Скрыть анонс
00:35 Drugs.com Breast Cancer Caught Earlier in U.S. States With Expanded Medicaid: Study

MONDAY, July 6, 2020 -- Early-stage breast cancer is more likely to be diagnosed in U.S. states that have expanded Medicaid coverage under Obamacare than in those that haven't, researchers say. Their new study looked at a database of more than...

Скрыть анонс
06.07.2020
22:47 Drugs.com Common Blood Pressure Meds May Lower Colon Cancer Risk

MONDAY, July 6, 2020 -- Millions of Americans take medication to keep their blood pressure down. A new study suggests that two types of blood pressure drugs might do double-duty, keeping colon cancer away, too. Angiotensin converting enzyme...

Скрыть анонс
22:26 ScienceDaily.com Novel protein drives cancer progression

Researchers have discovered a protein that drives the progression of esophageal cancer and liver cancer and it could be a promising target for cancer drug development.

Скрыть анонс
21:39 Drugs.com Obamacare Helps Poorer Americans Spot Cancer Earlier: Study

MONDAY, July 6, 2020 -- Medicaid expansion under Obamacare may have decreased the number of poorer Americans diagnosed with advanced cancer, a new study suggests. The study focused on Ohio, which was among the first states to expand its Medicaid...

Скрыть анонс
20:13 News-Medical.Net Study suggests new potential strategy to fight against pancreatic cancer

A University of Michigan-led study is shedding new light on the way pancreatic cancer cells turn nearby connective tissue cells into co-conspirators in their deadly growth.

Скрыть анонс
17:55 News-Medical.Net Study: Hypertension medications can also reduce risk of colorectal cancer

Medications commonly prescribed to treat high blood pressure may also reduce patients' colorectal cancer risk, according to new research published today in Hypertension, an American Heart Association journal.

Скрыть анонс
17:37 ScienceDaily.com Common hypertension medications may reduce colorectal cancer risk

People who take angiotensin converting enzyme inhibitors (ACE-i) or angiotensin II receptor blockers (ARBs) for conditions such as high blood pressure were less likely to be diagnosed with colorectal cancer after having a normal colonoscopy. This is the first study to show potential benefits on colorectal cancer development from these commonly prescribed hypertension medications, based on a study of more than 185,000 patients.

Скрыть анонс
17:27 News-Medical.Net Fertility can be successfully preserved in breast cancer patients, shows study

The first long-term record of how cancer patients made use of their stored eggs and embryos after cancer treatment is presented today at the 36th Annual Meeting of ESHRE.

Скрыть анонс
15:23 News-Medical.Net Using machine learning to analyze the interaction of breast cancer risk factors

A recently published article from University of Eastern Finland and Kuopio University Hospital reports new innovative use of machine learning to help understand the interplay of genetic and other breast cancer risk factors.

Скрыть анонс
11:32 ClinicalOncology.com Chronic Pain Common After Breast Cancer Surgery

Chronic post-op pain affects approximately one in every three women who undergo breast cancer surgery.

Скрыть анонс
05:27 BBC Health Coronavirus could cause 35,000 extra cancer deaths, experts warn

The research is based on the number of missed screenings, urgent referrals and delayed treatments.

Скрыть анонс
03.07.2020
16:04 AzoRobotics.com AI can Help Detect People at Risk of Developing Pancreatic Cancer

Dr Ananya Malhotra, research fellow in statistics, London School of Hygiene &Tropical Medicine, London, UK. Image Credit: ESMO Press Office. Early detection of pancreatic cancer is very...

Скрыть анонс
15:36 News-Medical.Net New scanner to detect early signs of bladder cancer could save thousands of lives

Thousands of lives lost to bladder cancers each year could be saved thanks to a new scanner that uses photonics to illuminate parts of the tissue that are currently impossible to visualize.

Скрыть анонс
15:21 News-Medical.Net Newly discovered endometrial cancer biomarker enables early detection and treatment

A newly discovered endometrial (uterine) cancer biomarker and diagnostic method will enable detection of the tumor type that is likely to spread and recur so that clinicians can initiate treatment early and stop the cancer from attacking other parts of the body.

Скрыть анонс
12:12 Technology.org Secrets of naked mole-rat cancer resistance unearthed

Naked mole-rats can live for an incredibly long time and have an exceptional resistance to cancer thanks to unique

Скрыть анонс
11:04 Technology.org Researchers find more precise way to target tumours with anti-cancer drugs

Researchers at the University of Alberta have found a way to deliver anti-cancer drugs with more precision, which

Скрыть анонс
10:10 AzoNano.com Nanoparticles Offer a Promising Way for Treating Cancer, Liver Disorders

University of Wisconsin-Madison researchers have developed a safer and more efficient way to deliver a promising new method for treating cancer and liver disorders and for vaccination -- including a...

Скрыть анонс
02:48 News-Medical.Net Researchers discover marine alga from Kiel Fjord as potential remedy against infections, skin cancer

Healing with the help of marine organisms is no utopia. Already 12 life-saving drugs, e.g. against cancer, have been developed from marine organisms and their symbiotic microbiota.

Скрыть анонс
02:32 News-Medical.Net Common chemotherapy drug may be less effective in overweight, obese breast cancer patients

Breast cancer patients who are overweight or obese might benefit less from treatment with docetaxel, a common chemotherapy drug, than lean patients.

Скрыть анонс
02.07.2020
20:15 ScienceDaily.com Marine algae from the Kiel Fjord discovered as a remedy against infections and skin cancer

Using state-of-the-art approaches coupled with bio- and cheminformatics and machine learning, researchers have succeeded in discovering new, bioactive components of the Baltic Sea Baltic Sea seaweed Fucus vesiculosus and its fungal symbiont against infectious bacteria or skin cancer.

Скрыть анонс
16:19 FierceBiotech.com MEI Pharma, Helsinn Group cut losses, ditch phase 3 partnered cancer test for pracinostat

MEI Pharma, Helsinn Group cut losses, ditch phase 3 partnered cancer test for pracinostat badams Thu, 07/02/2020 - 08:50

Скрыть анонс
13:40 ClinicalOncology.com Cancer and COVID-19: a Conversation With Elliot Newman, MD

On this episode of The Scope, we speak with Elliot Newman, MD, the chief of surgical oncology, pancreas and hepatobiliary surgery at Lenox Hill Hospital, and a professor of surgery at the Zucker School of Medicine at Hofstra/Northwell, about caring for cancer patients during the pandemic. 

Скрыть анонс
13:40 ClinicalOncology.com FDA Approves Phesgo for HER2-Positive Breast Cancer

The FDA granted approval to Genentech’s Phesgo, a fixed-dose combination of pertuzumab and trastuzumab with hyaluronidase, administered by subcutaneous injection in combination with IV chemotherapy, for the treatment of early and metastatic HER2-positive breast cancer.

Скрыть анонс
02:01 News-Medical.Net Moffitt develops tool to identify lung cancer patients at high risk for poorer outcomes

Lung cancer is the second most common cancer in both men and women in the United States. It is also the leading cause of cancer death among both sexes, making up nearly 25% of all cancer deaths nationwide.

Скрыть анонс
00:43 News-Medical.Net Women with breast cancer diagnosed at earlier stage in states with expanded Medicaid coverage

In a new study by Yale Cancer Center, researchers have demonstrated that in states with expanded Medicaid coverage through the Affordable Care Act a higher percentage of women with breast cancer had their disease diagnosed at an early stage.

Скрыть анонс
01.07.2020
23:14 Medscape.Com New Study Supports Treating Cancer Now

Dr David Kerr comments on a recent study that looked at one of the big unknowns when COVID-19 started: whether there is an increased risk for mortality for cancer patients undergoing chemotherapy.

Скрыть анонс
21:34 ScienceMag.org New forms of ‘red devil’ cancer drug could spare hearts

Insight into how compound kills cells might lead to safer variants of commonly used chemotherapy

Скрыть анонс
17:51 News-Medical.Net Inflammatory changes in tumors can cause drug resistance in cancer blood vessels

Scientists at Hokkaido University and collaborators have identified how inflammatory changes in tumors caused by chemotherapy trigger blood vessel anomalies and thus drug-resistance, resulting in the poor prognosis of cancer patients.

Скрыть анонс
15:15 News-Medical.Net NIH spearheads study to test at-home screening for HPV and cervical cancer

With a tiny brush, briefly swab the vagina to collect cells. Then slide the swab into a screening kit and drop it into the mail.

Скрыть анонс
13:42 News-Medical.Net Immunovia announces lung cancer program expansion based on encouraging study results

Immunovia AB today announced that the results of the current study in lung cancer strongly supports an expansion into the next stage in the discovery process.

Скрыть анонс
13:32 ClinicalOncology.com Pancreatic Cancer Rx Cost Falls With New Therapies

San Francisco—Even as drug costs skyrocketed over the past decade, the total cost of treating pancreatic cancer, adjusted for inflation, has declined.

Скрыть анонс
13:04 Technology.org Scientists uncovered the mechanism how carcinogens cause cancer

Pretty much half of us is going to get cancer. This is part and parcel of our stressful

Скрыть анонс
03:16 News-Medical.Net Researchers develop technique for personalizing stomach cancer therapy

Researchers from the Moscow Institute of Physics and Technology and their colleagues have developed the first technique for personalizing stomach cancer therapy based on RNA sequencing of tumor cells. The study, supported by the Russian Science Foundation, was published in Cold Spring Harbor Molecular Case Studies.

Скрыть анонс
03:16 News-Medical.Net Study links unexpected hospital stays to negative outcomes in head and neck cancer patients

Patients who were unexpectedly hospitalized for dehydration, fever or other ailments while undergoing radiation treatment for head and neck cancers were at a higher risk for less favorable outcomes, a new study from Roswell Park Comprehensive Cancer Center reports.

Скрыть анонс
02:23 News-Medical.Net Research shows IQGAP1 as a common target in variants of triple negative breast cancer

The cover for issue 26 of Oncotarget features Figure 6, "Mislocalization of IQGAP1-BRCA1 in human TNBC tumors phenocopies the dominant mutants and the TNBC cells," by Osman, et al. and reported that IQGAP1 is a signaling scaffold implicated in TNBC, but its mechanism is unknown.

Скрыть анонс
01:04 Medscape.Com Progress in Targeted Therapy for Lung Cancer: New Data

Dr Mark Kris explains why he is even more hopeful when it comes to targeted therapy for lung cancer after seeing several trial results presented during this year's virtual ASCO meeting.

Скрыть анонс
01:04 News-Medical.Net Scientists discover mechanism involving key protein that predicts cancer progression and relapse

Cancer cases have been rising over the years and according to the statistics, the number of people living with cancer will continue to increase.

Скрыть анонс
30.06.2020
22:47 ScienceDaily.com Glowing dye may aid in eliminating cancer

When a solid cancer is surgically removed, any small piece that is left behind increases the chance of a local recurrence or spread. In a pilot study of dogs with mammary tumors, a disease very similar to human breast cancer, a team found that an injectable dye, which glows under near-infrared light, illuminated cancerous growth in the primary tumor as well as in lymph nodes.

Скрыть анонс
21:19 Technology.org Immune Cells Infiltrating Tumors May Play Bigger Cancer Role Than Previously Thought

Most traditional cancer therapies target either the tumor cells themselves or indiscriminately kill any rapidly dividing cell. New

Скрыть анонс
20:31 ScienceDaily.com Discovery of key protein behind cancer relapse and progression can lead to new therapies

Reports show that cancer is the second-highest leading cause of death globally. A recent study by scientists provides new evidence supporting the presence of a key mechanism behind progression and relapse in cancer. The study discusses the role of MBNL1 protein as a biomarker for cancer prognosis, which can lead to the development of new treatment strategies for cancer.

Скрыть анонс
14:31 FierceBiotech.com Genmab, Seattle Genetics eye FDA filing for new cancer med after latest data drop

Genmab, Seattle Genetics eye FDA filing for new cancer med after latest data drop ntaylor Tue, 06/30/2020 - 03:58

Скрыть анонс
09:11 News-Medical.Net National Cancer Institute provides biospecimen banking support for NRG Oncology

The NRG Oncology Biospecimen Bank (NRG-BB) will be awarded six more years of funding from the National Cancer Institute (NCI) to provide biospecimen banking support for the NCI National Clinical Trials Network (NCTN) group NRG Oncology.

Скрыть анонс
08:56 News-Medical.Net Glitches in DNA replication have important implications for treating cancer

USC researchers peering deep inside a living cell have discovered something surprising: Its system for preventing genetic damage linked to diseases can fail so badly that the cell would be better off without it.

Скрыть анонс
08:30 News-Medical.Net HPV vaccine policies may lead to higher vaccination rates, reduce cancer rates

A UCLA-led study has found that in 2 of 3 states and jurisdictions with policies that require students entering school to receive the human papillomavirus vaccine, vaccination rates among 13-to-17-year-olds were significantly higher than in surrounding states without such policies.

Скрыть анонс
01:28 News-Medical.Net New agreements to increase access to cancer medicines and save countless lives

The American Cancer Society and the Clinton Health Access Initiative (CHAI) today announced agreements with pharmaceutical companies Pfizer, Novartis, and Mylan to expand access to 20 lifesaving cancer treatments in 26 countries in sub-Saharan Africa and Asia. Purchasers are expected to save an average of 59 percent for medicines procured through the agreements.

Скрыть анонс
29.06.2020
22:17 Technology.org Engineered immune cells recognize, attack human and mouse solid-tumor cancer cells

A method known as CAR-T therapy has been used successfully in patients with blood cancers such as lymphoma

Скрыть анонс
21:23 News-Medical.Net Enhanced photoacoustic imaging improves cancer staging

Prof. TIAN Chao's group from the Department of Precision Machinery and Instrumentation, University of Science and Technology of China of the Chinese Academy of Sciences has made progress on the photoacoustic imaging for medical science.

Скрыть анонс
20:23 ScienceDaily.com Engineered immune cells recognize, attack human and mouse solid-tumor cancer cells

CAR-T therapy has been used successfully in patients with blood cancers such as lymphoma and leukemia. It modifies a patient's own T-cells by adding a piece of an antibody that recognizes unique features on the surface of cancer cells. In a new study, researchers report that they have dramatically broadened the potential targets of this approach - their engineered T-cells attack a variety of solid-tumor cancer cells from humans and mice.

Скрыть анонс
20:16 Drugs.com How Insurance Plans Keep Black Patients From Cancer Care

MONDAY, June 29, 2020 -- Health insurance plans with high deductibles may be taking a financial toll on Black patients, according to a new study of cancer survivors. The researchers said the findings point to yet another reason for racial health...

Скрыть анонс
19:34 Phys.org Protein derived from tick saliva proves effective in the treatment of equine skin cancer

A protein derived from the saliva of the tick Amblyomma sculptum has been successfully used by researchers at the Butantan Institute in São Paulo, Brazil, to treat skin cancer (melanoma) in horses. The results of the study are described in the journal Scientific Reports.

Скрыть анонс
19:05 News-Medical.Net NUS researchers discover protein that promotes cancer progression

Cancers arise when the genetic code of normal cells is altered, causing excessive growth. Researchers from the Cancer Science Institute of Singapore at the National University of Singapore have discovered a protein that drives the growth of cancers of the esophagus or liver by altering the genetic code in a novel way.

Скрыть анонс
First← Previous12345678910Previous →Last